HRP980480A2 - Ureido and thioureido derivatives of 4-amino-2(5h) -furanones and 4-amino-2(5h)-thiophenones as antitumor agents - Google Patents

Ureido and thioureido derivatives of 4-amino-2(5h) -furanones and 4-amino-2(5h)-thiophenones as antitumor agents

Info

Publication number
HRP980480A2
HRP980480A2 HR97115391.1A HRP980480A HRP980480A2 HR P980480 A2 HRP980480 A2 HR P980480A2 HR P980480 A HRP980480 A HR P980480A HR P980480 A2 HRP980480 A2 HR P980480A2
Authority
HR
Croatia
Prior art keywords
aminocarbonylamino
alkyl
compounds
phenyl
furanone
Prior art date
Application number
HR97115391.1A
Other languages
English (en)
Croatian (hr)
Inventor
Gerd Zimmermann
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of HRP980480A2 publication Critical patent/HRP980480A2/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58One oxygen atom, e.g. butenolide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/66Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/32Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR97115391.1A 1997-09-05 1998-08-31 Ureido and thioureido derivatives of 4-amino-2(5h) -furanones and 4-amino-2(5h)-thiophenones as antitumor agents HRP980480A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97115391 1997-09-05

Publications (1)

Publication Number Publication Date
HRP980480A2 true HRP980480A2 (en) 1999-06-30

Family

ID=8227318

Family Applications (1)

Application Number Title Priority Date Filing Date
HR97115391.1A HRP980480A2 (en) 1997-09-05 1998-08-31 Ureido and thioureido derivatives of 4-amino-2(5h) -furanones and 4-amino-2(5h)-thiophenones as antitumor agents

Country Status (16)

Country Link
US (2) US6333346B1 (xx)
EP (1) EP1009747A1 (xx)
JP (1) JP2001515894A (xx)
KR (1) KR20010023549A (xx)
CN (1) CN1278256A (xx)
AR (1) AR014908A1 (xx)
AU (1) AU748490B2 (xx)
BR (1) BR9812629A (xx)
CA (1) CA2302284A1 (xx)
CO (1) CO4970714A1 (xx)
HR (1) HRP980480A2 (xx)
MA (1) MA24668A1 (xx)
PE (1) PE107599A1 (xx)
TR (1) TR200000589T2 (xx)
WO (1) WO1999012917A1 (xx)
ZA (1) ZA988096B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1309593B1 (it) * 1999-03-05 2002-01-24 Novuspharma Spa Composti eterociclici ad attivita' antitumorale.
KR20010094519A (ko) * 2000-03-31 2001-11-01 서경배 2,2,4,5-사중 치환된 3(2h)-퓨라논 유도체의 제조 방법
GB9928696D0 (en) 1999-12-03 2000-02-02 Swan Thomas & Co Ltd Optical devices and methods of manufacture thereof
IT1315267B1 (it) * 1999-12-23 2003-02-03 Novuspharma Spa Derivati di 2-(1h-indol-3-il)-2-oxo-acetammidi ad attivita'antitumorale
US20060211759A1 (en) * 2001-07-26 2006-09-21 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Bis-heterocyclic compounds with antitumour and chemosensitising activity
WO2003018575A1 (en) * 2001-08-24 2003-03-06 Wyeth Holdings Corporation 5-substituted-3(2h)-furanones useful for inhibition of farnesyl-protein transferase
US7649012B2 (en) * 2002-07-09 2010-01-19 Fasgen, Inc. Compounds, pharmaceutical compositions containing same, and methods of use for same
KR20040018295A (ko) * 2002-08-22 2004-03-03 임철부 항암 활성을 갖는 티오우레이도 세라마이드 유도체 및 이화합물을 함유하는 약학적 조성물
KR100555655B1 (ko) * 2002-11-20 2006-03-03 임철부 항암 활성을 갖는 우레이도 또는 티오우레이도 유도체 및이 화합물을 함유하는 약학조성물
CN1301253C (zh) * 2003-07-31 2007-02-21 中国人民解放军军事医学科学院毒物药物研究所 五元硫杂环类化合物及其用于制备治疗和预防肥胖相关疾病的药物的用途
CN101161645B (zh) * 2007-11-27 2010-06-23 南京大学 尿素类衍生物及其制备方法与用途
CN101560175B (zh) * 2009-05-08 2012-10-10 南京大学 一类硫脲类衍生物及其制备方法与用途
CN106800544B (zh) * 2017-01-19 2019-09-06 华南师范大学 3-卤-4-联苯胺基-2(5h)-呋喃酮类化合物及其在制备抗肿瘤药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE27894E (en) 1972-05-15 1974-01-22 Hydroxy-j-(j-phenylureido)crotonic acid, gamma lactone compounds
AR206143A1 (es) * 1974-04-17 1976-06-30 Du Pont Procedimiento para la preparacion de compuestos de 1 - t - alquil - 3 - (2,5 - dihidro - 5 - oxo - 3 - furil) ureas
SE7702004L (sv) * 1976-03-24 1977-09-25 Du Pont Antihypertensiva furylkarbamider
JPS63174983A (ja) * 1987-01-16 1988-07-19 Sumitomo Chem Co Ltd アミノブテノリド誘導体、その製造法およびそれを有効成分とする除草剤

Also Published As

Publication number Publication date
US6333346B1 (en) 2001-12-25
WO1999012917A1 (en) 1999-03-18
PE107599A1 (es) 1999-11-03
BR9812629A (pt) 2000-08-22
AR014908A1 (es) 2001-04-11
CN1278256A (zh) 2000-12-27
AU748490B2 (en) 2002-06-06
ZA988096B (en) 2000-03-22
MA24668A1 (fr) 1999-07-01
CA2302284A1 (en) 1999-03-18
AU9535098A (en) 1999-03-29
TR200000589T2 (tr) 2000-07-21
CO4970714A1 (es) 2000-11-07
EP1009747A1 (en) 2000-06-21
JP2001515894A (ja) 2001-09-25
KR20010023549A (ko) 2001-03-26
US20020058694A1 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
US5057614A (en) Substituted pyrroles
JP2006505571A (ja) 置換されたインドール及びhcv阻害剤としてのその使用
EP2518067B1 (fr) Dérives de n-[(1h-pyrazol-1-yl)aryl]-1h-indole ou 1h- indazole-3-carboxamide et leurs applications en thérapeutique comme antagonistes de p2y12.
JP2009519342A (ja) N−(6員芳香環)−アミド抗ウイルス化合物
HRP980480A2 (en) Ureido and thioureido derivatives of 4-amino-2(5h) -furanones and 4-amino-2(5h)-thiophenones as antitumor agents
MX2008012860A (es) Desazapurinas de utilidad como inhibidores de janus cinasas.
WO1991013071A1 (de) Neue trisubstituierte pyrrole, verfahren zur ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
JP2005526831A (ja) 医薬化合物
JPH0623193B2 (ja) 新規なジスタマイシンa同族体、その製造方法およびそれを含有する医薬組成物
WO1999000381A1 (en) Bis-indole derivatives having antimetastatic activity, a process for their preparation and pharmaceutical compositions containing them
BR112021000395A2 (pt) Compostos imunomoduladores diméricos contra mecanismos baseados em cereblon
EP0327986A2 (de) Arzeneimittel enthaltend Lactame, neue substituierte Lactame und Verfahren zu ihrer Herstellung
EP3838901B1 (en) Compound for treatment of rabies and method for treatment of rabies
WO2016039398A1 (ja) 含窒素複素環誘導体、神経保護剤及び癌治療用医薬組成物
US4785010A (en) 2-(aminoalkyl)-pyrrole derivatives, to treat disorders caused by restriction in cerebral function
DE68925270T2 (de) Pyrrolo[3,2-e]pyrazolo[1,5-a]pyrimidinderivate und diese enthaltende Arzneimittel
KR20150022707A (ko) 세포괴사 저해제로서의 인돌아미드 화합물
USRE36736E (en) Substituted pyrroles
CN112538038B (zh) 2-吲哚酮类ERRα反向激动剂及其药物组合物和应用
EP0575425A1 (de) VERWENDUNG VON OXAZOLO- 2,3-a]ISOINDOL- UND IMIDAZO 2,1-a]ISOINDOL-DERIVATEN ALS ANTIVIRALE ARZNEIMITTEL SOWIE NEUE OXAZOLO 2,3-a]ISOINDOL-DERIVATEN.
MXPA00002152A (en) Ureido and thioureido derivatives of 4-amino-2(5h)-furanones and 4-amino-2(5h)-thiophenones as antitumor agents
ITMI990456A1 (it) Composti eterociclici ad attivita' antitumorale
EP4104902A1 (en) Compound and drug containing same
AU689443B2 (en) Trifluoromethylpyrroloindole carboxylic ester derivative and process for producing the same
WO1992016529A1 (de) Neue isoindol-derivate und diese enthaltende arzneimittel

Legal Events

Date Code Title Description
A1OB Publication of a patent application
PNAN Change of the applicant name, address/residence

Owner name: ROCHE DIAGNOSTICS GMBH, DE

AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODBC Application rejected